98 related articles for article (PubMed ID: 26276142)
1. Systolic BP and Mortality in Older Adults with CKD.
Weiss JW; Peters D; Yang X; Petrik A; Smith DH; Johnson ES; Thorp ML; Morris C; O'Hare AM
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1553-9. PubMed ID: 26276142
[TBL] [Abstract][Full Text] [Related]
2. Time-Varying Association of Individual BP Components with eGFR in Late-Stage CKD.
Sood MM; Akbari A; Manuel D; Ruzicka M; Hiremath S; Zimmerman D; McCormick B; Taljaard M
Clin J Am Soc Nephrol; 2017 Jun; 12(6):904-911. PubMed ID: 28356338
[TBL] [Abstract][Full Text] [Related]
3. Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study.
Lee YB; Lee JS; Hong SH; Kim JA; Roh E; Yoo HJ; Baik SH; Choi KM
Sci Rep; 2021 Jan; 11(1):1538. PubMed ID: 33452422
[TBL] [Abstract][Full Text] [Related]
4. The association of SBP with mortality in patients with stage 1-4 chronic kidney disease.
Zhuo M; Yang D; Goldfarb-Rumyantzev A; Brown RS
J Hypertens; 2021 Nov; 39(11):2250-2257. PubMed ID: 34232158
[TBL] [Abstract][Full Text] [Related]
5. Relationship between systolic blood pressure and mortality in older vs younger trauma patients - a retrospective multicentre observational study.
Benhamed A; Batomen B; Boucher V; Yadav K; Isaac CJ; Mercier E; Bernard F; Blais-L'écuyer J; Tazarourte K; Emond M
BMC Emerg Med; 2023 Sep; 23(1):105. PubMed ID: 37726708
[TBL] [Abstract][Full Text] [Related]
6. Changing prediction of mortality by systolic blood pressure with increasing age: the Rotterdam study.
Blom JW; de Ruijter W; Witteman JC; Assendelft WJ; Breteler MM; Hofman A; Gussekloo J
Age (Dordr); 2013 Apr; 35(2):431-8. PubMed ID: 22170281
[TBL] [Abstract][Full Text] [Related]
7. BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues.
Navaneethan SD; Whaley-Connell A
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1501-3. PubMed ID: 26276139
[No Abstract] [Full Text] [Related]
8. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.
Navaneethan SD; Roy J; Tao K; Brecklin CS; Chen J; Deo R; Flack JM; Ojo AO; Plappert TJ; Raj DS; Saydain G; Sondheimer JH; Sood R; Steigerwalt SP; Townsend RR; Dweik RA; Rahman M;
J Am Soc Nephrol; 2016 Mar; 27(3):877-86. PubMed ID: 26386072
[TBL] [Abstract][Full Text] [Related]
9. Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury.
Whitaker RM; Stallons LJ; Kneff JE; Alge JL; Harmon JL; Rahn JJ; Arthur JM; Beeson CC; Chan SL; Schnellmann RG
Kidney Int; 2015 Dec; 88(6):1336-1344. PubMed ID: 26287315
[TBL] [Abstract][Full Text] [Related]
10. Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland.
Inker LA; Tighiouart H; Aspelund T; Gudnason V; Harris T; Indridason OS; Palsson R; Shastri S; Levey AS; Sarnak MJ
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1575-84. PubMed ID: 26286924
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.
Bu F; Borsa NG; Jones MB; Takanami E; Nishimura C; Hauer JJ; Azaiez H; Black-Ziegelbein EA; Meyer NC; Kolbe DL; Li Y; Frees K; Schnieders MJ; Thomas C; Nester C; Smith RJ
J Am Soc Nephrol; 2016 Apr; 27(4):1245-53. PubMed ID: 26283675
[TBL] [Abstract][Full Text] [Related]
12. T Lymphocyte-Specific Activation of Nrf2 Protects from AKI.
Noel S; Martina MN; Bandapalle S; Racusen LC; Potteti HR; Hamad AR; Reddy SP; Rabb H
J Am Soc Nephrol; 2015 Dec; 26(12):2989-3000. PubMed ID: 26293820
[TBL] [Abstract][Full Text] [Related]
13. Age and Outcomes Associated with BP in Patients with Incident CKD.
Kovesdy CP; Alrifai A; Gosmanova EO; Lu JL; Canada RB; Wall BM; Hung AM; Molnar MZ; Kalantar-Zadeh K
Clin J Am Soc Nephrol; 2016 May; 11(5):821-831. PubMed ID: 27103623
[TBL] [Abstract][Full Text] [Related]
14. Urinary Sodium and Potassium Excretion and CKD Progression.
He J; Mills KT; Appel LJ; Yang W; Chen J; Lee BT; Rosas SE; Porter A; Makos G; Weir MR; Hamm LL; Kusek JW;
J Am Soc Nephrol; 2016 Apr; 27(4):1202-12. PubMed ID: 26382905
[TBL] [Abstract][Full Text] [Related]
15. Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.
Brookhart MA; Freburger JK; Ellis AR; Winkelmayer WC; Wang L; Kshirsagar AV
Am J Kidney Dis; 2016 Jan; 67(1):119-27. PubMed ID: 26385819
[TBL] [Abstract][Full Text] [Related]
16. Serum Uric Acid and Risk of CKD in Type 2 Diabetes.
De Cosmo S; Viazzi F; Pacilli A; Giorda C; Ceriello A; Gentile S; Russo G; Rossi MC; Nicolucci A; Guida P; Feig D; Johnson RJ; Pontremoli R;
Clin J Am Soc Nephrol; 2015 Nov; 10(11):1921-9. PubMed ID: 26342044
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
19. Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR.
Koyner JL; Coca SG; Thiessen-Philbrook H; Patel UD; Shlipak MG; Garg AX; Parikh CR; ;
Am J Kidney Dis; 2015 Dec; 66(6):1006-14. PubMed ID: 26386737
[TBL] [Abstract][Full Text] [Related]
20. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry.
Pippias M; Jager KJ; Kramer A; Leivestad T; Sánchez MB; Caskey FJ; Collart F; Couchoud C; Dekker FW; Finne P; Fouque D; Heaf JG; Hemmelder MH; Kramar R; De Meester J; Noordzij M; Palsson R; Pascual J; Zurriaga O; Wanner C; Stel VS
Nephrol Dial Transplant; 2016 May; 31(5):831-41. PubMed ID: 26361801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
